)
Edge14 Nov 2025
Ball: The King of Cans
From a 19th-century glass-jar legacy to a global plant network, Ball is now a pure-play aluminum can partner to the world's biggest beverage brands.
CelLBxHealth plc (AGL) investor relations material
CelLBxHealth plc H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary9 Sep, 2025
Executive summary
Successfully completed three large pharma contracts and signed a major medtech collaboration with Myriad Genetics, expanding clinical and commercial opportunities despite revenue pressure from adverse market conditions.
Advanced DNA dual analysis workflow for CTC-DNA and ctDNA, and demonstrated integration with Illumina sequencing for enhanced cancer mutation detection.
NHS engagement for blood-based cancer diagnostics, with ongoing clinical lab accreditation and discussions with large pharma and medtech companies.
Eleven new peer-reviewed publications and pivotal research in cancer metastasis, including Nature Medicine publication on cluster buster drugs.
Over 270 Parsortix systems in use and more than 248,000 samples processed as of 30 June 2025.
Financial highlights
H1 2025 revenue was £0.8 million, down from £1.0 million in H1 2024, due to customer delays and challenging macro conditions.
Gross margin remained stable at 59% year-over-year.
Operating expenditure reduced by 12% to £8.0 million, and comprehensive loss reduced by 7% year-over-year.
Cash and R&D tax credits position at £6.6 million, with cash and cash equivalents at £5.3 million as of 30 June 2025; cash runway extends into Q1 2026.
Loss per share for H1 2025 was 2.87p, compared to 2.89p in H1 2024.
Outlook and guidance
Revenue for 2025 expected to exceed £1.5 million, with delays likely shifting further revenue into 2026.
Focus on securing additional funding in H2 from commercial milestones, collaborations, and potential equity or debt.
Anticipation of clinical lab accreditation by year-end to enable direct patient testing.
Pipeline includes multiple large pharma and medtech opportunities, NHS clinical studies, and new contracts.
How will Illumina partnership drive sales?
What is the NHS adoption pathway for Parsortix?
How will cluster buster drugs be commercialized?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next CelLBxHealth plc earnings date
Q3 202510 Dec, 2025
Next CelLBxHealth plc earnings date
Q3 202510 Dec, 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
ANGLE plc is a British medical diagnostics company focused on developing liquid biopsy solutions for cancer diagnostics. The company’s proprietary Parsortix system enables the capture and analysis of circulating tumor cells (CTCs) from patient blood samples, allowing for non-invasive cancer detection, monitoring, and personalized treatment insights. ANGLE’s technology is used in clinical research and trials, supporting advancements in oncology by providing real-time data on tumor progression and response to therapy. The company is headquartered in Guildford, United Kingdom, and its shares are listed on the London Stock Exchange and the Nasdaq.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage